Finance
Results: 6133-6144 of 41739

Syremis Therapeutics Launches with $165M to Develop Best-in-Class Medicines for Mental Health Conditions

Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management







